FOXO1 Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the FOXO1 gene, its protein product, associated diseases, and expression patterns.

Gene Information Card

Symbol FOXO1
Full Name forkhead box O1
Gene Type protein coding
Chromosomal Location 13q14.11
NCBI Gene ID 2308 ncbi.nlm.nih.gov/gene/2308
Ensembl ID ENSG00000150907
UniProt ID Q12778
OMIM ID 136533
HGNC ID 3819
Aliases FKHR, FOXO1A, forkhead in rhabdomyosarcoma

Description

FOXO1 (forkhead box O1) is a transcription factor belonging to the forkhead box O family. It regulates genes involved in cell cycle, apoptosis, glucose metabolism, oxidative stress response, and DNA repair. FOXO1 activity is modulated by post-translational modifications (phosphorylation, acetylation, ubiquitination) in response to growth factors and stress signals. It plays a critical role in insulin signaling and tumor suppression, and its dysregulation is implicated in various cancers and metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Rhabdomyosarcoma Chromosomal translocations (e.g., t(2;13)(q35;q14) or t(1;13)(p36;q14)) fuse FOXO1 with PAX3 or PAX7, creating oncogenic fusion proteins that disrupt myogenic differentiation and promote tumorigenesis. COSMIC, ClinVar, PMID: 28346458
Acute lymphoblastic leukemia (ALL) FOXO1 rearrangements (e.g., t(1;13)(p36;q14) with PAX7) are rare but associated with poor prognosis; fusion proteins alter transcriptional programs. COSMIC, PMID: 28637621
Alveolar rhabdomyosarcoma FOXO1 gene fusions (PAX3-FOXO1 or PAX7-FOXO1) are pathognomonic and drive aggressive tumor behavior. COSMIC, PMID: 28346458
Type 2 diabetes FOXO1 regulates hepatic gluconeogenesis; increased FOXO1 activity contributes to insulin resistance and hyperglycemia. OMIM, PMID: 15692564
Prostate cancer FOXO1 loss or cytoplasmic sequestration leads to increased cell proliferation and survival; reduced nuclear FOXO1 correlates with poor prognosis. PMID: 20534588
Breast cancer FOXO1 acts as a tumor suppressor; loss of expression or activity promotes epithelial-mesenchymal transition and metastasis. PMID: 22108914

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 12.4 Medium
Skeletal muscle 10.8 Medium
Liver 8.2 Low
Heart 7.5 Low
Brain 5.1 Low
Kidney 4.3 Low
Lung 3.2 Low
Spleen 2.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical adenocarcinoma; moderate expression
K-562 8.4 Chronic myelogenous leukemia; low expression
MCF7 12.1 Breast adenocarcinoma; moderate expression
A549 6.3 Lung carcinoma; low expression
HepG2 9.8 Hepatocellular carcinoma; moderate expression
T-47D 11.5 Breast ductal carcinoma; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
PAX3-FOXO1 fusion Chromosomal translocation t(2;13)(q35;q14) ~55% of alveolar rhabdomyosarcoma Oncogenic fusion protein with aberrant transcriptional activity
PAX7-FOXO1 fusion Chromosomal translocation t(1;13)(p36;q14) ~20% of alveolar rhabdomyosarcoma Oncogenic fusion protein; associated with younger age and better prognosis than PAX3-FOXO1
Missense mutations (e.g., p.Ser219Ala) Single nucleotide substitution Rare in cancers; frequency <1% May affect phosphorylation and nuclear localization
Deletions Loss of chromosomal region 13q14 Observed in some leukemias and lymphomas Loss of tumor suppressor function
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations (e.g., deletions, inactivating missense) reduce FOXO1 transcriptional activity, leading to unchecked cell proliferation and survival, contributing to tumorigenesis.

Gain of Function (GOF)

Gain-of-function is primarily seen in fusion proteins (PAX3/7-FOXO1) that acquire novel DNA-binding and transactivation domains, driving oncogenic gene expression programs.

Dominant Negative (DN)

Some FOXO1 mutants may act in a dominant-negative manner by competing with wild-type FOXO1 for DNA binding or cofactor interaction, thereby suppressing normal FOXO1 target gene expression.

Gene Ontology (GO)

• DNA-binding transcription factor activity • RNA polymerase II cis-regulatory region sequence-specific DNA binding
• protein binding • transcription coregulator binding
• nucleus • cytoplasm
• regulation of transcription by RNA polymerase II • apoptotic process
• cell cycle arrest • glucose homeostasis
• response to oxidative stress • insulin receptor signaling pathway

Pathways

PI3K-Akt signaling pathway
FoxO signaling pathway
Insulin signaling pathway
AMPK signaling pathway
Cell cycle regulation
Apoptosis signaling

Protein Summary

The FOXO1 protein (UniProt Q12778) is a 655-amino acid transcription factor with a conserved forkhead DNA-binding domain. It shuttles between nucleus and cytoplasm; phosphorylation by AKT at Thr24, Ser256, and Ser319 promotes cytoplasmic retention and inactivation. In the nucleus, FOXO1 binds to insulin response sequences (IRS) and regulates target genes such as p27, p21, Bim, and G6PC. Post-translational modifications (acetylation, ubiquitination) modulate its stability and activity. FOXO1 is critical for metabolic homeostasis and tumor suppression.

Related Products

Product name Cat.No. Species Gene ID
FOXO1 Knockout HEK293 Cell Line EDJ-KQ50280 Human 2308 Details Get a Quote
FOXO1 Knockout HeLa Cell Line EDJ-KQ53247 Human 2308 Details Get a Quote
FOXO1 Knockout A-549 Cell Line EDJ-KQ61729 Human 2308 Details Get a Quote
FOXO1 Knockout HCT 116 Cell Line EDJ-KQ70215 Human 2308 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: